RDS-127: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
== RDS-127 == | |||
<gallery> | |||
File:RDS-127 Structure.svg|RDS-127 Structure | |||
File:RDS-127 3D ball.png|RDS-127 3D Ball | |||
</gallery> | |||
Latest revision as of 01:40, 20 February 2025
RDS-127 is a drug that acts as a serotonin receptor agonist, specifically for the 5-HT1A receptor. It was one of the first drugs identified that is a selective agonist for this receptor, and was discovered in the early 1980s. RDS-127 is used in scientific research to understand the function of the 5-HT1A receptor.
History[edit]
RDS-127 was discovered in the early 1980s during research into drugs that could selectively target specific serotonin receptors. It was one of the first drugs identified that is a selective agonist for the 5-HT1A receptor, and has been used in scientific research to understand the function of this receptor.
Pharmacology[edit]
RDS-127 is a serotonin receptor agonist, specifically for the 5-HT1A receptor. This means it binds to and activates this receptor, which is one of several types of serotonin receptors in the brain. Activation of the 5-HT1A receptor by RDS-127 can have various effects, depending on the specific location in the brain where the receptor is activated.
Research Uses[edit]
RDS-127 is used in scientific research to study the function of the 5-HT1A receptor. It can be used in experiments to selectively activate this receptor, allowing researchers to understand its role in various brain functions and behaviors. RDS-127 has been used in studies investigating conditions such as anxiety, depression, and schizophrenia, which are thought to involve abnormalities in serotonin signaling.
